An upcoming pilot led by the UK Health Security Agency (UKHSA) across care homes in the South East is designed to support the early identification and management of acute respiratory outbreaks.
The pilot involves the use of multiplex lateral flow devices (LFDs) that can detect COVID-19, Influenza A, and Influenza B from a single nasal swab. Results are available within 15–30 minutes, helping providers to quickly determine if a respiratory outbreak may be present.
Key information:
• Multiplex LFD kits will be posted directly to all care homes in the South East, at no cost, with free replacements available via an online portal.
• These tests are intended for symptomatic residents only (not staff) and should be used when there is a suspected respiratory outbreak only, not an individual case
• A maximum of five residents may be tested per incident
• NHS COVID-19 LFDs should continue to be used as usual when assessing residents for COVID-19 treatment eligibility.
• Your GP should be contacted as usual to assess any patient with suspected Acute Respiratory Infection.
The aim of this pilot is to achieve:
• Assessment of the feasibility and usability in care settings
• Enable quicker decision-making around antiviral prophylaxis
• Support timely clinical action
• Improve overall outbreak management
• More appropriate use of antibiotics
• Capture staff and stakeholder feedback
• Inform future testing strategies
The pilot is expected to launch within the next few weeks, with an evaluation period running until 31 December 2025.
Further guidance, including instructions on use, a webinar, informational video and a FAQ sheet will be made available in due course by UKHSA.
Thank you for your continued support in protecting the health of residents and staff.